How to Buy Wegovy Online in the UK: Eligibility, Cost and Safety

If you have searched for how to buy Wegovy online in the UK, here is the short answer first: Wegovy (semaglutide) is a prescription-only medicine, so you cannot simply add it to a basket and check out. A legitimate UK pharmacy will only supply it after an online consultation and a clinical assessment by a prescriber, who confirms it is safe and appropriate for you. What you are really buying is a regulated treatment programme — the medicine, the prescriber's assessment, dose supervision and cold-chain delivery — not a product off a shelf.

That distinction matters, because the online weight-loss market has grown faster than its reputation for safety. This guide explains what a genuine, GPhC-registered process looks like, who is eligible under the current UK licence, what Wegovy realistically costs, what results the trials actually show, and what the first weeks feel like — in plain English, with the safety caveats included rather than buried.

Can you actually buy Wegovy online in the UK?

Yes — but only through a properly regulated route. Wegovy is a Prescription-Only Medicine (POM) in the UK, licensed by the Medicines and Healthcare products Regulatory Agency (MHRA). By law, a POM cannot be sold without a prescription issued by an appropriate healthcare professional after a clinical assessment. Any website offering to sell Wegovy "without a prescription" or "no consultation needed" is operating illegally, and you have no way of knowing what is actually in the pen.

A legitimate online pharmacy makes three things easy to verify:

• A GPhC registration. Every UK pharmacy must be registered with the General Pharmaceutical Council. Look for the registration number and check it against the public register. The Weight Clinic is GPhC-registered, with Andrew Lane (GPhC 2027876) as Superintendent Pharmacist.
• A real clinical assessment. You should complete a detailed medical questionnaire, not a token tick-box. Expect questions about your medical history, current medicines, and any conditions that would make treatment unsafe.
• A named prescriber. A qualified prescriber — a doctor or a pharmacist independent prescriber — reviews your answers and decides whether to prescribe. That is a clinical decision, and the answer is sometimes no.

The area to steer well clear of is the grey market: semaglutide sold through social media, messaging apps, or gym contacts. These products are frequently unlicensed, wrongly stored, or counterfeit. Semaglutide relies on an unbroken cold chain to stay effective, and a pen that has spent a week in a hot van tells you nothing about whether it will work — or whether it is even the drug on the label. The MHRA has repeatedly warned about illegally supplied weight-loss injections in the UK.

How Wegovy works

Wegovy's active ingredient is semaglutide, a GLP-1 receptor agonist. It mimics glucagon-like peptide-1, a hormone your gut releases after eating that signals fullness to the brain and helps regulate blood sugar. In practical terms, semaglutide does three things: it reduces appetite, so you feel satisfied on less food; it slows how quickly the stomach empties, so fullness lasts longer; and it dampens the intrusive "food noise" that derails many attempts at eating less.

It is not a fat-burner and it does not work by boosting metabolism. It changes the appetite signals that, for many people with obesity, have been working against them for years. That is also why it is used alongside — not instead of — changes to diet and activity. The medicine makes eating less feel achievable; the lifestyle changes are what make the result last.

Who is eligible to buy Wegovy in the UK?

Eligibility is set by the medicine's UK licence, and a responsible pharmacy will not prescribe outside it. Wegovy is licensed as an add-on to a reduced-calorie diet and increased physical activity for adults with:

• a BMI of 30 or above (obesity); or
• a BMI of 27 or above (overweight) with at least one weight-related health problem — for example type 2 diabetes, high blood pressure, high cholesterol, obstructive sleep apnoea, or heart disease.

Two points worth being clear about. First, these MHRA licence thresholds are broader than the stricter NICE criteria used to decide who the NHS will fund — which is one reason many people who don't qualify for NHS-funded treatment are still clinically eligible privately. Second, BMI is a screening tool, not the whole picture; a good prescriber considers your overall health, not just a single number.

Wegovy is not suitable for everyone. The one absolute contraindication in the product information is a known allergy (hypersensitivity) to semaglutide. Beyond that, there are important situations your prescriber needs to weigh up: tell them if you have a personal or family history of medullary thyroid cancer or the condition Multiple Endocrine Neoplasia syndrome type 2 (MEN2), and if you have ever had pancreatitis, as it may not be suitable in these cases. It is not recommended in pregnancy or while breastfeeding. This is exactly why the consultation exists — so a prescriber can review the full official product information against your history and decide whether Wegovy is right for you.

If you want to check your own numbers before starting, the online BMI assessment guide walks through how BMI is used clinically.

What results can you realistically expect?

This is where honesty matters most, because the headline figures are often quoted without their context. In the pivotal STEP-1 trial, adults without diabetes taking semaglutide 2.4 mg weekly lost an average of around 14.9% of body weight over 68 weeks, alongside lifestyle support — compared with about 2.4% on placebo. That is a genuinely large effect for a medicine, and it changed the field.

But averages hide a wide spread. Some people lose considerably more; some lose less. Results vary, and they depend on your starting weight, your genetics, how you respond to the drug, whether you reach and tolerate the maintenance dose, and the diet and activity changes you make alongside it. Wegovy is not a guarantee, and any clinic promising a specific number is overpromising.

It is also worth knowing the sister medicine. Mounjaro (tirzepatide), which acts on two gut hormones rather than one, produced an average of around 22.5% weight loss at the 15 mg dose over 72 weeks in the SURMOUNT-1 trial. Neither is universally "better" — the right choice depends on your health profile, tolerability and preference. If you are weighing them up, the Mounjaro vs Wegovy comparison sets the two out side by side.

The Wegovy dose schedule: starting low and building up

You do not start Wegovy at the full dose — doing so would almost guarantee severe nausea. Instead the dose is titrated: raised in steps over roughly four to five months so your body adjusts. The standard schedule moves through 0.25 mg, 0.5 mg, 1 mg and 1.7 mg before reaching the 2.4 mg maintenance dose, with each step usually held for around four weeks.

The 0.25 mg starting dose is deliberately low; it is there to let your body get used to the medicine, not to drive weight loss, so don't be discouraged if the scales barely move in month one. Crucially, dose increases are a clinical decision, not an automatic calendar event. If you are struggling with side effects at a given step, a good prescriber will hold you there — or slow the schedule — rather than push you up simply because four weeks have passed. Our guide to the Wegovy 0.25mg induction phase covers what those first weeks are like in more detail.

Side effects and safety

Most side effects of Wegovy are gastrointestinal and appear as the dose goes up. The common ones — nausea, diarrhoea, constipation, vomiting and reflux — affect a meaningful share of patients but are usually mild to moderate and tend to ease as the body adapts. Starting low and going slow is the single most effective way to keep them manageable. Eating smaller portions, avoiding very fatty meals, and staying hydrated all help.

Rarer but more serious risks exist and should not be glossed over. Semaglutide has been associated with pancreatitis (inflammation of the pancreas — severe, persistent stomach pain that may spread to the back is a red flag to seek urgent medical help) and with gallbladder problems, including gallstones. Because it can affect appetite and blood sugar, your prescriber will also want to know about any existing conditions and medicines, particularly diabetes treatments, some of which may need adjusting when you start.

This is also why the contraindications and cautions matter: your prescriber needs to know if you have a known allergy to semaglutide, any history of pancreatitis, or a personal or family history of medullary thyroid cancer or MEN2, and whether you are pregnant or breastfeeding. The online consultation is designed to surface exactly these details before any medicine is supplied.

If you experience a side effect you think may be linked to Wegovy, you can report it through the MHRA Yellow Card scheme at yellowcard.mhra.gov.uk. Reporting helps the Medicines and Healthcare products Regulatory Agency monitor the safety of medicines in real-world use, and it is something both patients and prescribers are encouraged to do.

For a fuller run-through, see our dedicated guide to Wegovy side effects.

What about the Wegovy Tablet?

An oral form of semaglutide has been a subject of considerable interest, since a tablet avoids injections entirely. The science here is real, but the details matter — dosing, how it is taken, and availability are not the same as the injectable pen. If a needle-free option is your priority, read our explainer on the Wegovy Tablet before assuming a tablet is a direct swap for the injection.

How much does Wegovy cost in the UK?

Private Wegovy pricing varies by clinic and by dose, and the honest answer is that "the cheapest pen" and "the safest service" are rarely the same listing. A fair price should include the medicine, the clinical assessment, the prescription and tracked cold-chain delivery — not just the vial.

At The Weight Clinic, Wegovy is £115 per month as standard, and your first month is from £80 with £35 off using the code NEWME on your first order. There is no subscription and no lock-in — you are not tied into a rolling contract, and the eligibility check is free. If you are comparing the two main options on cost, our breakdown of Mounjaro pricing is a useful companion (Mounjaro starts from £125 per month).

One cost that is invisible until it goes wrong is delivery. Wegovy must be kept refrigerated, and a pen posted in an ordinary envelope may have lost potency before it reaches you. Insist on temperature-controlled, tracked delivery — it is a safety standard, not a luxury. We cover why in our guide to Wegovy cold-chain delivery.

How it works at The Weight Clinic

The Weight Clinic is a GPhC-registered UK online pharmacy, with clinical oversight from Superintendent Pharmacist Andrew Lane and prescribing by pharmacist independent prescribers including Fatma Al Sibahi (GPhC 2232235). The process is deliberately straightforward:

1. Free eligibility check. You answer a detailed medical questionnaire online — no cost, no obligation.
2. Clinical assessment. A prescriber reviews your history and confirms whether Wegovy is safe and appropriate for you. Sometimes the safest answer is a different treatment, or none.
3. Dispensing and delivery. If approved, the medicine is dispensed from our registered pharmacy and sent in temperature-controlled, tracked packaging.
4. Ongoing support. As you move through the dose schedule, your prescriber supervises increases and helps you manage any side effects — no automatic escalations.

We will always encourage you to keep your GP informed so your records stay accurate and interactions are avoided. There is no subscription trap, and switching from another provider mid-titration is possible with evidence of your current dose.

Ready to find out whether Wegovy is right for you? Check your eligibility with a free, no-obligation consultation.

The bottom line

Buying Wegovy online in the UK is safe and legitimate when it runs through a GPhC-registered pharmacy, with a genuine clinical assessment, a named prescriber, honest pricing and cold-chain delivery. It is a prescription-only medicine with real benefits and real risks — the trials show meaningful average weight loss, but results vary, and the safety caveats are part of the deal, not the small print. Choose a provider that treats it as healthcare rather than retail, and the rest follows.